Federal Circuit Upholds Duty-Free Treatment for Pharmaceutical Ingredient
The Court of Appeals for the Federal Circuit in an April 26 opinion upheld a Court of International Trade ruling that gave duty-free treatment to darunavir ethanolate, the active ingredient in a HIV medication from drugmaker Janssen.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
Finding that the ingredient is in fact darunavir by another name, and therefore is included in Table 1 of the Pharmaceutical Appendix, the trade court ruled against the government's arguments that darunavir ethanolate has a different Chemical Abstracts Service (CAS) number, and is not a derivative listed in Table 2.